EIR Ventures
  • This is Eir Ventures
  • Team
  • Investments
  • ESG Policy
  • News
  • Contact
    • Investor Login
    • Download
Select Page
Interview with Eir Ventures’ Magnus Persson in Dagens Industri

Interview with Eir Ventures’ Magnus Persson in Dagens Industri

by EIRadmin202001 | Jan 25, 2021 | Other News

För 25 år sedan var han med och grundade Healthcap. Nu har Magnus Persson gjort det igen, med Eir Ventures, har han startat ett nytt bolag specialiserat på life science-investeringar. ”Sverige och Norden har länge visat sig fantastiskt när det gäller innovation”,...
New Nordic Life Science Venture Fund, Eir Ventures, launched to leverage the untapped potential of Health Care Innovation

New Nordic Life Science Venture Fund, Eir Ventures, launched to leverage the untapped potential of Health Care Innovation

by EIRadmin202001 | Jan 23, 2021 | Articles, Other News

Life sciences focused fund also announces first close of EUR76 million July 10, 2020, Stockholm & Copenhagen: Eir Ventures, a Nordic Life Science Venture Fund, today announced a first close of its new fund of EUR76 million. With a strong base in the Nordic region...

Recent Posts

  • Interview with Eir Ventures’ Magnus Persson in Dagens Industri
  • Interview with Eir Ventures’ Stephan Christgau in NASDAQ newsletter
  • New Nordic Life Science Venture Fund, Eir Ventures, launched to leverage the untapped potential of Health Care Innovation
  • Eir Ventures completes seed-financing of Sortina Pharma with GU Ventures to develop breakthrough cancer treatments
  • Eir Ventures is delighted to announce our participation in the over subscribed €127M series B round in IO Biotech

Recent Comments

    Get in Touch
    Eir Ventures is located in Stockholm, Sweden, and Copenhagen, Denmark.
    Sweden Office
    Grev Turegatan 27
    SE-114 38 Stockholm
    Sweden
    Denmark Office
    Havnegade 39
    DK-1058 Copenhagen
    Denmark
    Contact us
    info@eirventures.eu
    ©2021 Eir Ventures.